Tower Research Capital (TRC)’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.2K | Sell |
8,259
-399
| -5% | -$638 | ﹤0.01% | 3870 |
|
|
2025
Q1 | $10.6K | Buy |
8,658
+2,270
| +36% | +$2.77K | ﹤0.01% | 3625 |
|
|
2024
Q4 | $12.1K | Buy |
6,388
+4,438
| +228% | +$8.39K | ﹤0.01% | 3652 |
|
|
2024
Q3 | $10.4K | Sell |
1,950
-425
| -18% | -$2.27K | ﹤0.01% | 3762 |
|
|
2024
Q2 | $17.5K | Buy |
2,375
+1,865
| +366% | +$13.8K | ﹤0.01% | 3834 |
|
|
2024
Q1 | $6.09K | Sell |
510
-638
| -56% | -$7.62K | ﹤0.01% | 4434 |
|
|
2023
Q4 | $9.05K | Sell |
1,148
-1,182
| -51% | -$9.31K | ﹤0.01% | 4443 |
|
|
2023
Q3 | $10.3K | Buy |
2,330
+2,099
| +909% | +$9.28K | ﹤0.01% | 4127 |
|
|
2023
Q2 | $8.04K | Sell |
231
-946
| -80% | -$32.9K | ﹤0.01% | 4457 |
|
|
2023
Q1 | $26K | Buy |
1,177
+796
| +209% | +$17.6K | ﹤0.01% | 3163 |
|
|
2022
Q4 | $8K | Sell |
381
-1,724
| -82% | -$36.2K | ﹤0.01% | 4434 |
|
|
2022
Q3 | $51K | Buy |
2,105
+1,298
| +161% | +$31.4K | ﹤0.01% | 3141 |
|
|
2022
Q2 | $16K | Sell |
807
-3,115
| -79% | -$61.8K | ﹤0.01% | 4014 |
|
|
2022
Q1 | $139K | Buy |
3,922
+2,724
| +227% | +$96.5K | ﹤0.01% | 1990 |
|
|
2021
Q4 | $33K | Buy |
1,198
+234
| +24% | +$6.45K | ﹤0.01% | 3136 |
|
|
2021
Q3 | $42K | Buy |
964
+874
| +971% | +$38.1K | ﹤0.01% | 3095 |
|
|
2021
Q2 | $4K | Sell |
90
-1,129
| -93% | -$50.2K | ﹤0.01% | 4828 |
|
|
2021
Q1 | $55K | Buy |
1,219
+881
| +261% | +$39.8K | ﹤0.01% | 3047 |
|
|
2020
Q4 | $9K | Buy |
+338
| New | +$9K | ﹤0.01% | 4393 |
|
|
2016
Q4 | – | Sell |
-4
| Closed | -$3K | – | 4246 |
|
|
2016
Q3 | $3K | Hold |
4
| – | – | ﹤0.01% | 2873 |
|
|
2016
Q2 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 3936 |
|